Jean Mulinde from CDER’s Office of Scientific Investigations describes the casic characteristics of clinical trials of quality. She discusses the roles that quality management systems, quality by design principles, and risk-based monitoring play in ensuring data reliability and trial participant protection in the clinical development of new medicinal products.
For more data integrity case studies, visit www.fda.gov/dr...
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming training and free continuing education credits: www.fda.gov/cd...
CDER SBIA 2018 Playlist: • 2018 CDER Small Busine...
LinkedIn: / cder-small-business-an...
Training resources: www.fda.gov/cd...
Twitter: / fda_drug_info
CDER small business e-mail update subscription: updates.fda.go...
Email: CDERSBIA@fda.hhs.gov
Phone: (301) 796-6707 I (866) 405-5367
Негізгі бет Quality Management Systems and Quality By Design (3of11) GCP Data Integrity Workshop
No video
Пікірлер